• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在原位,组织转谷氨酰胺酶对tau进行修饰:多胺化可能产生的功能和代谢影响。

Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination.

作者信息

Tucholski J, Kuret J, Johnson G V

机构信息

Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, 35294-0017, USA.

出版信息

J Neurochem. 1999 Nov;73(5):1871-80.

PMID:10537045
Abstract

Tissue transglutaminase (tTG) is up-regulated in Alzheimer's disease brain and localizes to neurofibrillary tangles with the tau protein. Tau is an in vitro tTG substrate, being cross-linked and/or polyaminated. Further, the Gln and Lys residues in tau that are modified by tTG in vitro are located primarily within or adjacent to the microtubule-binding domains. Considering these and other previous findings, this study was carried out to determine if tau is modified in situ by tTG in human neuroblastoma SH-SY5Y cells, and whether tTG-catalyzed tau polyamination modulates the function and/or metabolism of tau in vitro. For these studies, SH-SY5Y cells stably overexpressing tTG were used. tTG coimmunoprecipitated with tau, and elevating intracellular calcium levels with maitotoxin resulted in a 52 +/- 4% increase in the amount of tTG that coimmunoprecipitated with tau. The increase in association of tTG with tau after treatment with maitotoxin corresponded to a coimmunolocalization of tTG, tTG activity, and tau in the cells. Further, tau was modified by tTG in situ in response to maitotoxin treatment. In vitro polyaminated tau was significantly less susceptible to micro-calpain proteolysis; however, tTG-mediated polyamination of tau did not significantly alter the microtubule-binding capacity of tau. Thus, tau interacts with and is modified by tTG in situ, and modification of tau by tTG alters its metabolism. These data indicate that tau is likely to be modified physiologically and pathophysiologically by tTG, and tTG may play a role in Alzheimer's disease.

摘要

组织转谷氨酰胺酶(tTG)在阿尔茨海默病大脑中上调,并与tau蛋白一起定位于神经原纤维缠结中。Tau是tTG的体外底物,会发生交联和/或多胺化。此外,tau中在体外被tTG修饰的Gln和Lys残基主要位于微管结合域内或其附近。考虑到这些及其他先前的研究结果,本研究旨在确定在人神经母细胞瘤SH-SY5Y细胞中tau是否在原位被tTG修饰,以及tTG催化的tau多胺化是否在体外调节tau的功能和/或代谢。对于这些研究,使用了稳定过表达tTG的SH-SY5Y细胞。tTG与tau共免疫沉淀,用 maitotoxin提高细胞内钙水平导致与tau共免疫沉淀的tTG量增加了52±4%。用maitotoxin处理后tTG与tau结合的增加对应于细胞中tTG、tTG活性和tau的共免疫定位。此外,响应maitotoxin处理,tau在原位被tTG修饰。体外多胺化的tau对微钙蛋白酶解的敏感性显著降低;然而,tTG介导的tau多胺化并未显著改变tau的微管结合能力。因此,tau在原位与tTG相互作用并被其修饰,tTG对tau的修饰改变了其代谢。这些数据表明tau可能在生理和病理生理上被tTG修饰,并且tTG可能在阿尔茨海默病中起作用。

相似文献

1
Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination.在原位,组织转谷氨酰胺酶对tau进行修饰:多胺化可能产生的功能和代谢影响。
J Neurochem. 1999 Nov;73(5):1871-80.
2
Tissue transglutaminase is an in situ substrate of calpain: regulation of activity.组织转谷氨酰胺酶是钙蛋白酶的一种原位底物:活性调节。
J Neurochem. 1998 Jul;71(1):240-7. doi: 10.1046/j.1471-4159.1998.71010240.x.
3
Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.钙和鸟苷三磷酸对组织转谷氨酰胺酶原位活性的调节作用
J Biol Chem. 1998 Jan 23;273(4):2288-95. doi: 10.1074/jbc.273.4.2288.
4
Modification of tau to an Alzheimer's type protein interferes with its interaction with microtubules.tau蛋白向阿尔茨海默病型蛋白的转变会干扰其与微管的相互作用。
Cell Mol Biol (Noisy-le-grand). 1998 Nov;44(7):1117-27.
5
Maitotoxin induces calpain activation in SH-SY5Y neuroblastoma cells and cerebrocortical cultures.刺尾鱼毒素可诱导人神经母细胞瘤细胞(SH-SY5Y)和大脑皮质培养物中的钙蛋白酶激活。
Arch Biochem Biophys. 1996 Jul 15;331(2):208-14. doi: 10.1006/abbi.1996.0300.
6
The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?神经元钙传感器蛋白VILIP-1与阿尔茨海默病中的淀粉样斑块和细胞外缠结相关,并在体外促进细胞死亡和tau蛋白磷酸化:钙传感器与阿尔茨海默病之间的联系?
Neurobiol Dis. 2001 Oct;8(5):900-9. doi: 10.1006/nbdi.2001.0432.
7
Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.钙蛋白酶在急性损伤的神经元细胞中将细胞周期蛋白依赖性激酶5激活剂p35加工成其截短形式(p25)。
Biochem Biophys Res Commun. 2000 Jul 21;274(1):16-21. doi: 10.1006/bbrc.2000.3070.
8
Impaired mitochondrial function results in increased tissue transglutaminase activity in situ.线粒体功能受损导致组织转谷氨酰胺酶原位活性增加。
J Neurochem. 2000 Nov;75(5):1951-61. doi: 10.1046/j.1471-4159.2000.0751951.x.
9
Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.α1-抗糜蛋白酶是一种在阿尔茨海默病大脑中过度表达的炎症蛋白,可诱导神经元中的tau蛋白磷酸化。
Brain. 2006 Nov;129(Pt 11):3020-34. doi: 10.1093/brain/awl255. Epub 2006 Sep 20.
10
Nitration and oligomerization of tau induced by peroxynitrite inhibit its microtubule-binding activity.过氧亚硝酸盐诱导的tau蛋白硝化和寡聚化会抑制其微管结合活性。
FEBS Lett. 2005 Apr 25;579(11):2421-7. doi: 10.1016/j.febslet.2005.03.041.

引用本文的文献

1
Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases.转谷氨酰胺酶 2 在神经退行性疾病中的发病机制贡献和治疗意义。
Int J Mol Sci. 2024 Feb 17;25(4):2364. doi: 10.3390/ijms25042364.
2
Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer's disease.人源过度表达 tau 蛋白的小鼠重现了早期阿尔茨海默病的脑干受累和神经精神特征。
Acta Neuropathol Commun. 2023 Apr 3;11(1):57. doi: 10.1186/s40478-023-01546-5.
3
Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis.
转谷氨酰胺酶 2 在细胞死亡、存活和纤维化中的作用。
Cells. 2021 Jul 20;10(7):1842. doi: 10.3390/cells10071842.
4
Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin.微管相关蛋白 tau 作为生物标志物在具有上皮来源的癌症中对紫杉烷类治疗的反应和增加疗效的双重作用。
Pharmacol Res. 2021 Jun;168:105585. doi: 10.1016/j.phrs.2021.105585. Epub 2021 Mar 30.
5
Discovery of sultam-containing small-molecule disruptors of the huntingtin-calmodulin protein-protein interaction.含磺内酰胺的亨廷顿蛋白-钙调蛋白蛋白质-蛋白质相互作用小分子干扰剂的发现。
Med Chem Res. 2020 Jul;29(7):1187-1198. doi: 10.1007/s00044-020-02583-8. Epub 2020 Jun 12.
6
Ablation of polyamine catabolic enzymes provokes Purkinje cell damage, neuroinflammation, and severe ataxia.多胺分解代谢酶的消融会导致浦肯野细胞损伤、神经炎症和严重的共济失调。
J Neuroinflammation. 2020 Oct 14;17(1):301. doi: 10.1186/s12974-020-01955-6.
7
New insight into transglutaminase 2 and link to neurodegenerative diseases.转谷氨酰胺酶 2 的新见解及其与神经退行性疾病的联系。
BMB Rep. 2018 Jan;51(1):5-13. doi: 10.5483/bmbrep.2018.51.1.227.
8
Amyloidogenesis of Tau protein.Tau蛋白的淀粉样变
Protein Sci. 2017 Nov;26(11):2126-2150. doi: 10.1002/pro.3275. Epub 2017 Sep 13.
9
Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death.转谷氨酰胺酶2在细胞功能调控以及细胞生长和死亡过程中发挥着相反的作用。
Cell Death Dis. 2016 Jun 2;7(6):e2244. doi: 10.1038/cddis.2016.150.
10
Targeting innate immunity for neurodegenerative disorders of the central nervous system.针对中枢神经系统神经退行性疾病的先天性免疫治疗
J Neurochem. 2016 Sep;138(5):653-93. doi: 10.1111/jnc.13667.